Loading your page…
Each register with its number of medicines and a few of them.
AEMPS · 1 medicine
EMA · 1 medicine · Historical list
PHARMAC · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Granupas (previously Para-aminosalicylic acid Lucane) | European Union | Withdrawn | Eurocept International B. V. | ||
| GRANUPAS 4 g granulado gastrorresistente | Spain | 4 g | granulado gastrorresistente | Authorised | Eurocept International B.V. |
| Paser | New Zealand | Grans for oral liq 4 g | Funded | ||
| Parasal | United States | 1GM, 500MG | tablet | Not marketed | Panray |
| 5-Aminosalicylic Acid | Taiwan | （粉） | Cancelled | 立信藥品有限公司 | |
| NTP-5-Aminosalicylic Acid | Canada | 400 MG | Tablet (Enteric-Coated) | Cancelled | Teva Canada Limited |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, EMA and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
